Zhang and colleagues suggested that zeste homolog 2 (EZH2) activating TGF-β signaling via activating FAK signaling, using FAK inhibitors, can effectively inhibit BC bone metastasis in vivo [226, 241, 274]. The gene discussed is TGFB1; the disease is breast cancer.